| Literature DB >> 33271998 |
Franziska Beck1, Nicoleta Ilie1.
Abstract
Antioxidants are known for their potential of strengthening the collagen network when applied to dentin. They establish new intra-/intermolecular bonds in the collagen, rendering it less perceptive to enzymatic hydrolysis. The study evaluated the benefit on shear bond strength (SBS) of a resin-composite to dentin when antioxidants with different biomolecular mechanisms or a known inhibitor of enzymatic activity are introduced to the bonding process in a clinically inspired protocol. Specimens (900) were prepared consistent with the requirements for a macro SBS-test. Four agents (Epigallocatechingallate (EGCG), Chlorhexidindigluconate (CHX), Proanthocyanidin (PA), and Hesperidin (HPN)) were applied on dentin, either incorporated in the primer of a two-step self-etch adhesive or as an aqueous solution before applying the adhesive. Bonding protocol executed according to the manufacturer's information served as control. Groups (n=20) were tested after one week, one month, three months, six months, or one year immersion times (37 °C, distilled water). After six-month immersion, superior SBS were identified in PA compared to all other agents (p<0.01) and a higher reliability in both primer and solution application when compared to control. After one year, both PA incorporated test groups demonstrated the most reliable outcome. SBS can benefit from the application of antioxidants. The use of PA in clinics might help extending the lifespan of resin-based restorations.Entities:
Keywords: adhesion to dentin; antioxidants; bond strength; chlorhexidindigluconate; epigallocatechingallate; hesperidin; proanthocyanidin
Year: 2020 PMID: 33271998 PMCID: PMC7729620 DOI: 10.3390/ma13235483
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Illustration of sample preparation and bonding procedure: (1) schematic presentation of the cutting procedure; (2) schematic presentation of the cross-section of each tooth half; (3) embedding of the dentin substrate in methacrylic resin; (4) placement of the adhesive paper (with a centered circle-round hole; diameter of 3.16 mm) on the specimen to limit the bonding area; (5) placement of the vinyl polysiloxane split mold with a cylindric cavity (diameter of 3.16 mm and height of 4 mm); (6) schematic presentation of the resin–composite placement and light curing; and (7) restored final specimen.
Characterization and composition of materials.
| Commercial Name, Manufacturer, LOT Number | Type of Material | Main Components | Instructions for Use |
|---|---|---|---|
|
| Two-step self-etch adhesive | Primer: 2-Hydroxyethylmethacrylat 10-Metharyloyloxydecyl-dihydrogenphosphate Hydrophilic aliphatic dimethacrylate dl-campherchinone accelerators water dyes | Apply primer to the entire cavity wall for 20 s and dry with mild air for more than 5 s until the PRIMER does not move; |
| Adhesive: bisphenol A diglycidylmethacrylate 2-hydroxyethyl metharylate 10-methacryloyloxydecyl dihydrogen phosphate Hydrophobic aliphatic dimethacrylate Colloidal silica dl-campherquinone initiators accelerators | Apply bond to the entire cavity wall and make a uniform bond film using a gentle air flow;Light-cure bond with a dental curing unit for 10 s | ||
|
| Nanohybrid-ORMOCER bulk-fillresin-composite | Matrix:ORMOCERFillers:Based on silicon oxide (84 wt.%) | Apply in ≤ 4 mm increments;Light cure for 40 s |
Figure 2Description of the test groups; each tested after one week, one month, three months, six months, and one year.
Figure 3Graphics illustrating specimen dimensions and testing.
Mean and standard deviation of SBS as a function of immersion duration; p-values signify the ANOVA results of each column/row; different lowercase letters indicate significant differences in a column tested by Tukey’s post-hoc analysis.
| Bond | EGCG | CHX | PA | HPN | Control | ANOVA | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Primer | Solution | Primer | Solution | Primer | Solution | Primer | Solution | |||
| One week | 12.68 | 12.53 | 11.41 | 13.18 | 12.49 | 12.66 | 15.12 | 12.10 | 14.10 | |
| One month | 11.78 | 10.84 | 13.80 | 15.59 | 17.03 | 13.53 | 16.68 | 15.35 | 17.66 | |
| Three months | 12.30 | 13.29 | 11.50 | 15.84 | 19.23 | 15.43 | 16.42 | 12.59 | 14.29 | |
| Six months | 12.11 | 10.56 | 9.69 | 12.18 | 15.08 | 14.85 | 10.10 | 12.68 | 14.49 | |
| One year | 8.42 | 13.35 | 10.41 | 14.63 | 14.36 | 15.17 | 13.12 | 14.41 | 13.58 | |
| ANOVA | ||||||||||
Weibull modulus m, confidence interval (95%), coefficient of determination R2, and characteristic strength calculated for each test group.
| Weibull Modulus m, Confidence Interval (95%), R2 and σθ (MPa) |
EGCG | CHX | PA | HPN | Control | ||||
|---|---|---|---|---|---|---|---|---|---|
| Primer | Solution | Primer | Solution | Primer | Solution | Primer | Solution | ||
| One week | 3.30 (0.24) | 2.66 (0.37) | 3.15 (0.44) | 3.46 (0.46) | 3.00 (0.28) | 2.81 (0.32) | 4.35 (0.25) | 2.32 (0.26) | 4.67 (0.39) |
| One month | 3.59 (0.37) | 2.65 (0.16) | 2.46 (0.21) | 4.06 (0.47) | 5.03 (0.62) | 2.89 (0.44) | 2.77 (0.29) | 4.82 (0.44) | 3.24 (0.36) |
| Three months | 2.61 (0.15) | 2.95 (0.36) | 3.75 (0.41) | 5.66 (0.44) | 9.41 (0.99) | 3.23 (0.17) | 2.46 (0.39) | 3.30 (0.29) | 2.27 (0.30) |
| Six months | 2.93 (0.47) | 3.15 (0.18) | 2.88 (0.20) | 2.63 (0.13) | 5.50 (0.40) | 3.95 (0.21) | 2.35 (0.24) | 3.35 (0.35) | 2.79 (0.28) |
| One year | 2.19 (0.16) | 3.18 (0.38) | 2.57 (0.28) | 3.31 (0.58) | 5.72 (0.60) | 6.12 (0.86) | 2.68 (0.17) | 3.91 (0.35) | 4.00 (0.25) |
Figure 4Example of Weibull graphs for the shortest (one week) (a,b) and longest (one year) (c,d) immersion durations and both antioxidant application protocols: (a) one week, primer; (b) one week, solution; (c) one year, primer; and (d) one year, solution.
Fracture analysis of the test groups as a function of immersion duration. Prevalence of the defined fracture patterns is presented in percent (in total in brackets). Superscript letters identify fracture mechanism: a, adhesive; m, mixed; c, cohesive.
| Fracture |
EGCG | CHX | PA | HPN | Control | In Total | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Primer | Solution | Primer | Solution | Primer | Solution | Primer | Solution | |||
| 1 week | 70% (14) a | 55% (11) a | 80% (16) a | 45% (9) a | 45% (9) a | 60% (12) a | 30% (6) a | 45% (9) a | 55% (11) a | 52.8% (95) a |
| 1 month | 65% (13) a | 60% (12) a | 75% (15) a | 30% (6) a | 35% (7) a | 60% (12) a | 30% (6) a | 35% (7) a | 15% (3) a | 45% (81) a |
| 3 months | 75% (15) a | 85% (17) a | 85% (17) a | 60% (12) a | 40% (8) a | 60% (12) a | 55% (11) a | 50% (10) a | 60% (12) a | 63.3% (114) a |
| 6 months | 55% (11) a | 70% (14) a | 90% (18) a | 60% (12) a | 45% (9) a | 70% (14) a | 65% (13) a | 50% (10) a | 70% (14) a | 63.9% (115) a |
| 1 year | 75% (15) a | 50% (10) a | 60% (12) a | 45% (9) a | 45% (9) a | 45% (9) a | 40% (8) a | 40% (8) a | 35% (7) a | 48.3% (87) a |
| In total | 68% (68) a | 62% (62) a | 78% (78) a | 48% (48) a | 42% (42) a | 59% (59) a | 44% (44) a | 44% (44) a | 47% (47) a | 54.7% (492) a |